PL3137473T3 - Pochodne Pt (iv) i zawierające je nanonośniki - Google Patents

Pochodne Pt (iv) i zawierające je nanonośniki

Info

Publication number
PL3137473T3
PL3137473T3 PL15724777T PL15724777T PL3137473T3 PL 3137473 T3 PL3137473 T3 PL 3137473T3 PL 15724777 T PL15724777 T PL 15724777T PL 15724777 T PL15724777 T PL 15724777T PL 3137473 T3 PL3137473 T3 PL 3137473T3
Authority
PL
Poland
Prior art keywords
nanocarriers
derivatives
Prior art date
Application number
PL15724777T
Other languages
English (en)
Inventor
Simon Benita
Taher Nassar
Dan Gibson
Aiman ABU AMMAR
Original Assignee
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. filed Critical Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
Publication of PL3137473T3 publication Critical patent/PL3137473T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15724777T 2014-05-02 2015-04-30 Pochodne Pt (iv) i zawierające je nanonośniki PL3137473T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461987717P 2014-05-02 2014-05-02
EP15724777.6A EP3137473B1 (en) 2014-05-02 2015-04-30 Pt (iv) derivatives and nanocarriers comprising them
PCT/IL2015/050448 WO2015166498A1 (en) 2014-05-02 2015-04-30 Pt (iv) derivatives and nanocarriers comprising them

Publications (1)

Publication Number Publication Date
PL3137473T3 true PL3137473T3 (pl) 2020-06-01

Family

ID=53267424

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15724777T PL3137473T3 (pl) 2014-05-02 2015-04-30 Pochodne Pt (iv) i zawierające je nanonośniki

Country Status (6)

Country Link
US (1) US10239903B2 (pl)
EP (1) EP3137473B1 (pl)
CN (1) CN106471006B (pl)
ES (1) ES2774662T3 (pl)
PL (1) PL3137473T3 (pl)
WO (1) WO2015166498A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397643A1 (en) 2015-12-30 2018-11-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pt(IV) PRODRUGS
CN105561331A (zh) * 2016-01-26 2016-05-11 北京大学 饱和脂肪酸修饰的抗肿瘤药物偶联物及其自组装纳米系统和制备方法
CN106619568B (zh) * 2016-12-09 2020-01-17 浙江大学 一种铂纳米晶复合纳米材料的制备方法及产品
EP3810622A4 (en) * 2018-06-21 2022-04-06 NanoMed Holdings Pty Ltd PLATINUM BASED AMPHIPHILIC PRODRUGS
US20220251126A1 (en) 2019-08-05 2022-08-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anticancer agents
WO2021167703A1 (en) 2020-02-19 2021-08-26 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof
WO2022038605A1 (en) 2020-08-20 2022-02-24 Bionanosim (Bns) Ltd Lipid delivery systems for delivery of oxaliplatin palmitate acetate
CN114259483A (zh) * 2020-09-16 2022-04-01 广州中医药大学第一附属医院 一种用于治疗肝细胞癌的药物组合物及其应用
CN114539320B (zh) * 2020-11-25 2026-01-27 北京大学 辐射激活的四价铂配合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6296A (ja) * 1985-03-06 1987-01-06 Sumitomo Pharmaceut Co Ltd 脂溶性白金(2)錯体
EP0646589A3 (en) 1993-10-04 1995-06-28 Tanaka Precious Metal Ind Anti-tumor platinum (IV) complexes.
WO2015013565A1 (en) 2013-07-25 2015-01-29 Nemucore Medical Innovations, Inc. Platinum derivatives for hydrophobic formulations
WO2015013566A1 (en) 2013-07-25 2015-01-29 Nemucore Medical Innovations, Inc. Nanoemulsions of hydrophobic platinum derivative
WO2015058111A1 (en) 2013-10-17 2015-04-23 The Brigham And Women's Hospital, Inc. Cationic nanoparticles for co-delivery of nucleic acids and thereapeutic agents

Also Published As

Publication number Publication date
US20170081352A1 (en) 2017-03-23
CN106471006B (zh) 2020-04-24
CN106471006A (zh) 2017-03-01
WO2015166498A1 (en) 2015-11-05
US10239903B2 (en) 2019-03-26
EP3137473B1 (en) 2019-11-27
EP3137473A1 (en) 2017-03-08
ES2774662T3 (es) 2020-07-22

Similar Documents

Publication Publication Date Title
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
EP3164170A4 (en) Glucagon administration system and methods
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
EP3177183A4 (en) Therapeutic cushion systems and methods
EP3102258A4 (en) Self-priming systems and methods
EP3092286A4 (en) Ethylene-to-liquids systems and methods
EP3154972A4 (en) Azamophinan derivatives and use thereof
PL3137473T3 (pl) Pochodne Pt (iv) i zawierające je nanonośniki
IL248030A0 (en) History of Cannabidiol Quinone
EP3215585A4 (en) Proppant and proppant delivery system
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
GB201408673D0 (en) Medicaments,uses and methods
EP3213769A4 (en) Transdermal-absorption-promoter and transdermal-absorption-promoting supplement
EP3238725A4 (en) Poultice
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
GB201416293D0 (en) Methods and preparations
IL248773A0 (en) History of naphthyridinedione
SG11201606199SA (en) Ketoprofen-containing poultice
ZA201702901B (en) Stabilized adrenomedullin derivatives and use thereof
EP3096610A4 (en) Egg-breaking systems and methods
ZA201607919B (en) Dipicolylamine derivatives and their pharmaceutical uses
AP2016009530A0 (en) Cycloalkyl-linked diheterocycle derivatives
EP3237377A4 (en) Vitamin d3 derivatives and pharmaceutical use thereof
EP3120724A4 (en) Detachable structure and object comprising same
GB201417092D0 (en) Systems and methods for state connections